While most forms of immunotherapies, such as checkpoint blockade, work for many patients, not all patients respond to treatment. University of Chicago researchers have identified barriers to response and are working to develop better therapies that can help more patients.
For more on the groundbreaking impact of immunotherapy, read The Immunotherapy Revolution in Science Life, or listen to a podcast about Andrew Parker, a leukemia patient who underwent experimental cellular therapy after failed chemotherapy treatments:
UChicago's Jason Luke discusses melanoma on Facebook Live
Jason Luke, MD, of the University of Chicago Medicine, joined Stephanie Goff, MD, of the National Cancer Institute (NCI) for an NCI Facebook Live event to discuss current research and treatment options for advanced stage melanoma. Jamie Troil-Goldfarb, a metastatic melanoma survivor, moderated the event.
Playing on, with cancer
An accomplished jazz pianist, Billy Foster mastered improv long ago. For the past 10 years, he has drawn on that talent as he and his University of Chicago Medicine team tried various medications to control his metastatic kidney cancer. A hopeful and sustained note was struck in 2013 when Foster began taking the medication axitinib.
Black women are far more likely than white women to die from breast cancer. Olufunmilayo Olopade, MD, professor of medicine and human genetics at the University of Chicago, is part of a team using genomic and proteomic data to understand why. Their initial findings, published in JAMA Oncology and covered in Crain’s Chicago Business, could lead to more personalized risk assessment and new ways to diagnose and treat specific subtypes of aggressive breast cancers.
Chicago attorney John Cooney fights for his clients with mesothelioma in the courtroom as well as outside it as an advocate for medical research and funding. Mesothelioma, a cancer caused by exposure to asbestos, most often affects the lungs and has a poor prognosis and no cure.
Raymon Grogan, MD, assistant professor of surgery, has been making news. His study that found pancreatic cancer patients survive longer when they go to a major cancer center for treatment was featured in Consumer Affairs. Meanwhile, his UChicago Medicine surgical team, co-led by Zhen Gooi, MD, also made news for becoming the first in the Midwest and the fourth in the country to remove diseased thyroid or parathyroid glands using an approach that leaves no visible scar. Read more to find out how it is done.
Associates Board members
Annual Fund the Fight Ball raises over $37,000 for cancer research
The University of Chicago Cancer Research Foundation (UCCRF) Associates Board raised over $37,000 at its annual Fund the Fight Ball on April 22 at the Columbia Yacht Club. More than 200 donors attended the event, which featured a silent auction, raffle, wine toss, photo booth, and music by Dr. Feelgood and the Yacht Rockers. Monies raised at the event helps the UCCRF Associates Board surpass its $500,000 in total giving to the Comprehensive Cancer Center.
Chicago Kicking Cancer
Saturday, August 19, 2017
Winnemac Park, Chicago
Simon M. Shubitz Award Ceremony and Annual Foundation Dinner
Monday, September 25, 2017
The Four Seasons Hotel
UCCRF Women's Board
Annual Grand Auction
Saturday, November 11, 2017
The Four Seasons Hotel